Modern Chinese Medicine (HKG:1643) expects a net loss of not less than 13 million yuan for 2025, compared with a net profit of about 9.7 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.
The expected loss is due to the loss of certain distributors, reduced purchase orders, and the exclusion of some key products from the national medical insurance list, which weighed on sales.
The company said its annual results are expected to be published by the end of March.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.